Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy

Cardiac resynchronization therapy represents a therapeutic option for heart failure drug-refractory patients. However, due to the lack of success in 30% of the cases, there is a demand for an in-depth analysis of individual heterogeneity. In this study, we aimed to evaluate the prognostic value of c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Isabel Moscoso, María Cebro-Márquez, Álvaro Martínez-Gómez, Charigan Abou-Jokh, María Amparo Martínez-Monzonís, José Luis Martínez-Sande, Laila González-Melchor, Javier García-Seara, Xesús Alberte Fernández-López, Sandra Moraña-Fernández, José R. González-Juanatey, Moisés Rodríguez-Mañero, Ricardo Lage
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-01-01
coleção:	Cells
Assuntos:	heart failure adverse remodelling cardiac resynchronization therapy microRNAs cardiac biomarker cardiac therapeutic target
Acesso em linha:	https://www.mdpi.com/2073-4409/11/2/271
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!